The Harvard Medical School Center for Palliative Care is delighted to highlight the following fellowship opportunities:
Harvard Interprofessional Palliative Care Fellowship Program
The Harvard Interprofessional Palliative Care Fellowship Program is a one-year clinical program that trains future leaders in the comprehensive, interdisciplinary care of seriously ill patients and their families.
For more information and links to apply, please visit https://www.hipcf.org/.
Harvard Interprofessional Pediatric Palliative Care Fellowship
The Harvard Interprofessional Pediatric Palliative Care Fellowship is an innovative, clinically intensive, one-year training program that immerses postgraduate clinicians in pediatric medicine, social work, and advanced practice nursing in a truly interprofessional educational environment. The three Pediatric Fellowship opportunities include:
- The Physician (MD) fellowship is an ACGME-accredited program in Hospice and Palliative Medicine through Boston Children's Hospital. Applications open July 1st, 2025 - August 15th, 2025 and are due August 15th, 2025.
- The Nurse Practitioner (NP) fellowship provide subspecialty training in pediatric palliative care. Applications are open November 1st, 2024 - January 3rd, 2025 and are due January 3rd, 2025.
- The Social Work (SW) fellowship provides subspecialty training in pediatric palliative care. Applications open November 1st, 2024 - March 1st, 2025 and are due March 1st, 2025.
For more information, please visit the progam website.
Dana-Farber Cancer Institute Research Fellowship in Psychosocial Oncology and Palliative Care
This two-year research fellowship opportunity can follow the year of clinical training. The program is directed toward physicians, psychologists, doctorally prepared nurses, social workers, and other clinicians who wish to prepare themselves for an academic research career in palliative care or psychosocial oncology. The goal of this fellowship is to train early investigators prepared to move these fields forward through the conduct of highest-quality research. A separate application is required. For more information, visit their website or contact POPCResearchFellowship@partners.org.
Dana-Farber PGY-2 Pain Management/Palliative Care Pharmacy Residency
The Dana-Farber PGY-2 Pain Management and Palliative Care Pharmacy Residency is designed to provide the resident with opportunities to develop clinical competence in pain management and palliative care in various settings, including inpatient and outpatient palliative care, hospice, inpatient and outpatient pain management, and pain management in the primary care setting.
The experience is enhanced through integration with the Harvard Interprofessional Palliative Care Fellowship Program, which provides a nationally rare opportunity for a pharmacy resident to join a fellowship with physician and nurse practitioner fellows in both adult and pediatric palliative care. The program offers didactic and experiential learning geared toward the health care professional working with an interdisciplinary team. Residents who complete the program will develop as role models for clinical pharmacists, advance their teaching skills, work on a publishable research or quality project.
For more information, please consult the program website: Pharmacy Residency Programs | Dana-Farber Cancer Institute. The application deadline is January 6, 2025 and the program will begin during the first week of July 2025.
Harvard Beth Israel-VA Boston HPM Fellowship Program
The Harvard Beth Israel-VA Boston Fellowship is a one-year physician fellowship. The program's mission is to train the next generation of clinicians, educators, team members, and thought leaders working to advance the care of patients and caregivers facing serious illness. As a partnership between Beth Israel Deaconess Medical Center (BIDMC) and the Boston VA, the program has a strong focus on medical education, and a proud tradition of providing fellows with breadth and depth of exposure to diverse patient populations across multiple palliative care teams and hospice teams in different care settings. Our graduates come from diverse backgrounds and clinical specialties, and have gone on to advance hospice and palliative care here in Boston, across the United States, and around the world.
The BI-VA Fellowship trains three physicians per year. One slot per year is available for combined training in Hematology/Oncology and Hospice & Palliative Medicine, as part of a 3-year integrated fellowship offered in collaboration with the Divisions of Hematology/Oncology at Beth Israel Deaconess Medical Center (BIDMC).
For more information and links to apply, please visit our fellowship website. Applications are accepted through ERAS each July, with an application deadline of August 1st.
For more information about the integrated Hematology/Oncology and Hospice & Palliative Medicine ("HOHPM") fellowship, please click here. Applications are accepted through ERAS each July, as a track within the BIDMC Hematology/Oncology fellowship program.
MGH Bridge-the-Gap T32 Fellowship Program (mghbridgethegap.org)
Bridging the Science-to-Service Gap: Prevention, Optimization and Living Well with Persistent or Serious Illness
INTERDISCIPLINARY RESEARCH FELLOWSHIP (T32) PROGRAM
**2025 Cohort Applications and Letters of Recommendation Due November 18, 2024**
Please email mghBridgetheGap@mgb.org
This postdoctoral fellowship program will address the pressing need for strengthening and diversifying the pipeline for well-trained clinician investigators with a specific focus on caring for older individuals or those with persistent or serious illness, and their care-partners. Fellows with a commitment to clinical and behavioral research will have the opportunities for interdisciplinary training that cuts across departments. The program instills the skills needed to initiate and lead rigorous research at the highest levels of quality. Fellows will develop mentored clinical research projects that use the NIH stage model and will receive experiential training through their mentors’ NIH-funded clinical trials.